Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block vs Wound Infiltration for Analgesia After Cesarean Delivery
NCT03498118Completed
- Sponsor
- Aswan University Hospital
- Start
- Jan 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Aswan University Hospital. Primary endpoint: Cumulative opioid consumption at 24 hours. Started Jan 2018; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03498118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03498118.